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Objectives: Cardiovascular disease is often associated with COPD. Lung density quantification 
of images obtained from cardiac computed tomography (CT) scans would allow simultaneous 
evaluation of emphysema and coronary artery calcification score and provide further mechanistic 
insight into the relationship between these syndromes.
Patients and methods: We assessed the agreement between lung density indices obtained by 
cardiac and full-lung CT scans. Paired cardiac and chest CT scans were assessed in 156 individuals 
with and without airflow limitation. Quantitative threshold indices of low attenuation area 
(LAA) and 15th percentile density index (PD15) were compared in terms of precision using 
Spearman’s correlation coefficient, accuracy using concordance correlation coefficient (CCC), 
and relative accuracy using P15 and P30. We also assessed the relationship between visually 
and quantitatively determined emphysema and used receiver operating characteristic curves to 
evaluate the ability of lung density indices to discriminate airflow limitation.
Results: Correlation coefficients between lung density indices obtained from cardiac and chest 
CT scans were 0.49 for percent LAA (%LAA)-950 and 0.71 for PD15. Corresponding values for 
CCC, P15, and P30 were 0.33, 3.2, and 5.1, respectively, for %LAA-950, and 0.34, 17.3, and 37.8, 
respectively, for PD15. For both cardiac and chest CT scans, visually determined emphysema 
was associated with higher %LAA-950 and lower PD15, and the ability of %LAA-950 and 
PD15 to discriminate airflow limitation were comparable.
Conclusion: Although chest CT imaging is preferable, cardiac CT imaging may also be used 
for lung emphysema quantification where association measures are of primary interest.
Keywords: agreement, cardiac CT, chest CT, chronic obstructive pulmonary disease, emphy-
sema, lung density
Introduction
Cardiovascular disease is often associated with COPD.1–4 Whether the association 
is due to shared risk factors or other undiscovered mechanisms is still unknown. 
Cardiac computed tomography (CT) imaging has been increasingly used both in 
clinical settings and for cardiovascular research, particularly for the determination of 
coronary artery calcium (CAC) score, which is believed to be an important predictor 
for future cardiovascular events and mortality.5,6 Although cardiac CT imaging has not 
been traditionally used for the determination of lung density indices, as the entire lung 
volume is not scanned, its use for quantification of lung emphysema would provide 
further insight into the mechanistic relationship between cardiovascular disease and 
COPD.7–9 Furthermore, assessment of both degree of CAC score and lung emphysema 
during cardiac CT imaging would provide important diagnostic information with 
therapeutic consequences in a clinical setting.
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In the present study, we assessed the agreement between 
lung density indices from cardiac and chest CT for lung 
emphysema quantification. For this purpose, we included 
HIV-infected individuals, as these individuals would be 
expected to represent a broader disease spectrum10 and 
uninfected individuals from the general population. In addi-
tion, individuals with and without airflow limitation were 
included. First, we assessed the precision and accuracy of 
well-established lung density indices. Second, we assessed 
the ability of lung density indices to discriminate airflow 
limitation and the relationship between visual emphysema 
and quantitative measures of lung density.
Patients and methods
study design and patient selection
Subjects who had undergone paired unenhanced chest and 
ECG-gated cardiac CT scans were randomly recruited from 
the Copenhagen Co-morbidity in HIV-infection (COCOMO) 
study and the Copenhagen General Population Study (CGPS). 
The COCOMO study is a cohort that tracks non-AIDS dis-
eases in HIV-infected individuals in Denmark.11 The CGPS 
is a cohort study of the general population of Denmark.12 
HIV-infected individuals were included, as these individuals 
have a higher burden of tobacco smoking and were expected 
to have more lung emphysema compared to individuals 
from the general population.10 In addition, we intended 
to include individuals with and without airflow limitation 
(approximately one-third of the entire study population). 
The study was approved by the Regional Ethics Committee 
of Copenhagen (H-15017350; H-KF-01-144/01). Written 
informed consent was obtained from all participants.
Spirometry and other measurements
All participants completed a comprehensive questionnaire 
about smoking and underwent a physical examination, 
including pre-bronchodilatory spirometry; details regard-
ing data collection and procedures have previously been 
described.13 Predicted values for FEV
1
 and FVC were cal-
culated according to the Global Lung Function Initiative 
(GLI).14 Airflow limitation was defined spirometrically as 
FEV
1
/FVC ,the lower limit of normal (LLN), calculated 
according to the GLI, and as FEV
1
/FVC ,0.7.
CT scanning procedure
All individuals underwent a paired unenhanced chest CT and 
electrocardiography (ECG)-gated cardiac CT scans; details 
regarding the scan protocol and scan parameters have previ-
ously been described.11,12 In brief, an Aquilion One Vision 
Edition scanner (Toshiba Medical Systems, Otawara, Japan) 
was used for both image acquisitions with the following set-
tings: 120 kVp (both CT modalities), automated exposure 
control (SD15 and SD55), and reconstruction with filtered 
back projection and a soft tissue kernel (1 mm slice thickness) 
for chest CT scans and 3 mm slice thickness and interval 
for ECG-gated cardiac CT scans. Both CT modalities were 
acquired in sequence during the same visit. The chest CT was 
acquired during a deep inspiratory breath-hold, whereas the 
cardiac CT was acquired during a normal inspiratory breath-
hold (around 50% of maximum lung capacity). Chest CT was 
acquired using spiral image acquisition including the entire 
lungs, whereas cardiac CT was acquired using ECG-gated, 
single rotation with a Z-axis from 8 to 16 cm depending on 
heart length in the Z-axis.
Emphysema scoring
For chest CT, lung emphysema was quantified using low 
attenuation area (LAA) #950 Hounsfield units and the 15th 
percentile density index (PD15).15 While there is at least 
some consensus regarding the optimal %LAA threshold for 
chest CT, there is no consensus regarding optimal %LAA 
cutoff values for cardiac CT, but differences in lung volumes 
and acquisition parameters are likely to be of influence.16,17 
In addition to PD15, we therefore included a number of 
different cutoff values for the %LAA (-910 to -950). 
A representative cardiac CT slice is found in Figure S1. 
Furthermore, chest CT scans were also evaluated visually 
for lung emphysema using a 6-point semiquantitative scale. 
Visual lung emphysema was determined for the entire 
lung by a radiologist (author: TK) using a well-defined 
scoring system:18 score 0 =0% (none), 1 =1%–10% (trace), 
2 =11%–25% (mild), 3 =26%–50% (moderate), 4 =51%–75% 
(severe), and 5 .75% (very severe) visual emphysema of the 
lung. Visual assessment was performed blinded to the quan-
titative analysis. Visual lung emphysema was dichotomized 
prior to analysis. Manual correction of lung segmentation was 
performed if the software failed to automatically and fully 
identify the whole lung parenchyma. Images obtained from 
chest CT and cardiac CT scans were scored using a dedicated 
lung density program Vitrea (Vital Images, Minnetonka, 
MN, USA).
statistical analyses
Paired t-tests were used for comparisons of lung volumes 
obtained by chest and cardiac CT scans. Wilcoxon’s rank-
sum test was used for comparisons of lung density indices 
in scans with and without visual emphysema. Correlations 
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between the various emphysema indices were compared 
using Spearman’s rho (ρ) due to the skewed and heterosce-
dastic nature of the data. We evaluated accuracy using 
concordance correlation coefficient (CCC), defined as 
CCC = r×C
b
, where r is the Pearson’s correlation coefficient 
(a measure of precision) and C
b
 is a bias correction factor 
that measures how far the best-fit line deviates from the 45° 
line through the origin (a measure of accuracy).19 We also 
calculated relative accuracy, defined as the cumulative 
percentage of cardiac CT scan emphysema indices falling 
within 15% (P15) or within 30% (P30) of chest CT emphy-
sema indices. Agreement between PD15 by chest CT and 
PD15 by cardiac CT was evaluated using a Bland–Altman 
plot. Performance characteristics were evaluated by receiver 
operating characteristics (ROC) curves and area under the 
curve (AUC). In sensitivity analyses, we confined results to 
individuals without HIV infection. A P-value ,0.05 was 
used to infer statistical significance. Statistical analyses were 
performed using R software version 3.3.2 (R Foundation for 
Statistical Computing, Vienna, Austria).
Results
Clinical and scan characteristics
In total, 156 individuals underwent paired cardiac and 
chest CT scanning. Most participants were white males 
aged .50 years with a relatively even distribution of current, 
former, and never-smokers (Table 1). Approximately, one-
third of the study population had airflow limitation. Although 
mean (SD) lung volumes were significantly different between 
cardiac and chest CT scans (2.8 [0.9] L vs 5.8 [1.5] L, 
P,0.0001), the lung volumes correlated well with each other 
(ρ=0.72, P,0.0001). The lung density program was unable to 
automatically and fully identify the whole lung parenchyma 
in 24 (15%) cases of cardiac CT scans. Thus, a minor form of 
manual correction was necessary for these individuals. Mean 
(SD) lung volume increased from 2.3 (0.8) L to 3.3 (0.8) L, 
P,0.0001, in those cardiac CT scans that required a manual 
correction; however, the manual correction did not change 
mean values of %LAA or PD15; for %LAA-950 =Δ0.04 
(2.1)%, P=0.93, and for PD15 =Δ0.6 (7.8) g/L, P=0.72.
association and agreement of lung 
density indices between cardiac and 
chest CT
In general, different thresholds of %LAA and PD15 from 
cardiac CT scans were at least moderately associated with 
%LAA-950 and PD15 obtained by chest CT scans. The 
highest correlation coefficient was obtained by PD15 from 
cardiac CT vs PD15 from chest CT (ρ=0.71, P,0.0001) 
(Table 2). The lowest correlation coefficient was obtained by 
%LAA-950 from cardiac CT vs %LAA-950 from chest CT 
(ρ=0.49, P,0.0001). Accounting the %LAA measures and 
PD15 for cardiac CT volumes did not significantly improve 
the correlation coefficients (Table 2). In contrast, the accu-
racy for all lung density indices from cardiac CT scans was 
poor (Table 2); %LAA-950 from cardiac CT vs %LAA-950 
from chest CT CCC =0.33, P15 =3.2, and P30 =5.1, and 
PD15 from cardiac CT vs PD15 from chest CT CCC =0.34, 
P15 =17.3, and P30 =37.8. Likewise, the limits of agreement 
for PD15 were also wide with relatively many points in the 
Bland–Altman plot far from the mean (Figure 1). Similar 
results were observed in analyses restricted to individuals 
without HIV infection (Table S1). Furthermore, correlation 
coefficients for individuals with airflow limitation, defined as 
FEV
1
/FVC ,LLN, were high for both %LAA-950 and PD15; 
for %LAA-950: ρ=0.68, P,0.0001, and for PD15: ρ=0.66, 
Table 1 Characteristics of study population
Study 
participants 
(n=156)
age groups
,35 years, n (%) 1 (0.6)
35–44 years, n (%) 18 (11.5)
45–54 years, n (%) 49 (31.4)
.55 years, n (%) 88 (56.4)
Male, n (%) 112 (71.8)
Caucasians, n (%) 146 (93.6)
BMI (kg/m2), mean (sD) 24.4 (4.2)
HIV-infected, n (%) 105 (67.3)
smoking status
Current smokers, n (%) 55 (35.3)
Former smokers, n (%) 55 (35.3)
Never-smokers, n (%) 42 (26.9)
Tobacco consumption in pack-years,a median (IQr) 15.5 (0.0–34.0)
Airflow limitation
FeV1/FVC ,lln, n (%) 49 (31.4)
FeV1/FVC ,0.7,
b n (%) 85 (54.5)
Severity of airflow limitation
FeV1 predicted .80%, n (%) 99 (63.5)
FeV1 predicted 50%–79%, n (%) 46 (29.5)
FeV1 predicted 30%–49%, n (%) 9 (5.8)
FeV1 predicted ,30%, n (%) 2 (1.3)
%LAA-950 by chest CT, median (range) 2.2 (0.0–18.2)
%LAA-950 by cardiac CT, median (range) 0.0 (0.0–1.0)
PD15 (g/L) by chest CT, mean (SD) 107.9 (21.7)
PD15 (g/l) by cardiac CT, mean (sD) 147.9 (38.5)
%LAA-950 .5% by chest CT, n (%) 45 (29.2%)
Notes: Data are summarized as median and IQr or number (percent). If percentages 
in each category do not add to 100% it is due to missing values. aPack-year is 
calculated for entire cohort. bPre-bronchodilatory spirometric indices.
Abbreviations: BMI, body mass index; IQR, interquartile range; %LAA-950, 
percent low attenuation area #950 Hounsfield units; LLN, lower limit of normal.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
5.
98
.2
16
 o
n 
19
-D
ec
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2018:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3324
ronit et al
P,0.0001. In contrast, correlation coefficient for individuals 
without airflow limitation were low for %LAA-950 but 
high for PD15; for %LAA-950: ρ=0.36, P,0.001, and for 
PD15: ρ=0.72, P,0.0001.
association between lung density indices 
and airflow limitation
Individuals with high values of %LAA-950 were more likely 
to have low values of FEV
1
% predicted for both cardiac 
Table 2 Correlation and agreement between lung emphysema by cardiac and chest CT (n=156)
ρ ρcorrecteda P-valueb CCC P15 (%) P30 (%)
%LAA-910 cardiac CT vs %LAA-950 chest CT 0.67 0.68 ,0.0001 0.50 5.1 12.8
%LAA-920 cardiac CT vs %LAA-950 chest CT 0.63 0.65 ,0.0001 0.61 5.1 16.2
%LAA-930 cardiac CT vs %LAA-950 chest CT 0.60 0.60 ,0.0001 0.60 5.1 12.2
%LAA-940 cardiac CT vs %LAA-950 chest CT 0.50 0.50 ,0.0001 0.45 3.9 6.4
%LAA-950 cardiac CT vs %LAA-950 chest CT 0.49 0.50 ,0.0001 0.33 3.2 5.1
PD15 cardiac CT vs PD15 chest CT 0.71 0.61 ,0.0001 0.34 17.3 37.8
Notes: aCorrelation coefficient where measurements obtained by cardiac CT were corrected for cardiac CT lung volume. bP-value for Spearman’s correlation coefficient 
rho (ρ). P15/P30, relative accuracy.
Abbreviations: CCC, concordance correlation coefficient; %LAA, percent low attenuation area; PD15, 15th percentile density index.
Figure 1 Association between lung density indices measured by cardiac and chest CT.
Notes: (A) PD15 by chest CT vs PD15 by cardiac CT and (B) Bland–Altman plot of PD15 by chest CT vs PD15 by cardiac CT. Ninety-five percent limits of agreement 
(-12.7–93.1). The correlation between the difference of the two measures and the average of the two measures was assessed using Kendall’s rank correlation tau and found 
to be correlated (tau =-0.45, P,0.0001).
Abbreviations: CT, computed tomography; PD15, 15th percentile density index.
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and chest CT (Figure 2). Performance characteristics were 
used to compare the ability of two modalities to classify 
airflow limitation defined as FEV
1
/FVC , LLN. ROC 
curves for %LAA-950 and PD-15 from chest CT and car-
diac CT scans are depicted in Figure 3. Neither %LAA-950 
nor PD15 was a good discriminator for airflow limitation; 
AUC for %LAA-950 was 0.66 (95% CI: 0.55–0.78) and for 
PD15 was 0.64 (95% CI: 0.53–0.75) in cardiac CT, and for 
%LAA-950 was 0.62 (95% CI: 0.51–0.73) and for PD15 
was 0.62 (95% CI: 0.51–0.73) in chest CT. For individuals 
without HIV infection, the values for AUC seemed higher; 
AUC for %LAA-950 was 0.66 and for PD15 was 0.75 in 
cardiac CT, and for %LAA-950 was 0.70 and for PD15 was 
0.77 in chest CT.
Figure 2 Association between lung density indices measured by chest (A) and cardiac (B) CT and FeV1%-predicted.
Abbreviations: CT, computed tomography; %LAA-950, percent low attenuation area #950 Hounsfield units.
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Figure 3 ROC curves for the ability of lung density indices to discriminate airflow limitation.
Notes: rOC curves for (A) %LAA-950 from chest CT with AUC 0.62 (95% CI: 0.51–0.73) and cardiac CT with AUC 0.66 (95% CI: 0.55–0.78) and (B) PD15 from chest CT 
with AUC 0.62 (95% CI: 0.51–0.73) and cardiac CT with AUC 0.64 (95% CI: 0.53–0.75). Airflow limitation was defined as FEV1/FVC ,lln.
Abbreviations: AUC, area under the curve; %LAA-950, percent low attenuation area #950 Hounsfield units; LLN, lower limit of normal; PD15, 15th percentile density 
index; ROC, receiver operating characteristics.
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association between visually and 
quantitatively assessed lung emphysema 
for cardiac and chest CT
Individuals with visually determined lung emphysema on 
chest CT had higher median [IQR] values of %LAA-950 
compared to individuals without visually determined lung 
emphysema on both chest CT (score 2.0 [1.0–5.0] vs score 4.5 
[1.6–11.2], P,0.01) and cardiac CT (score 0.0 [0.0–0.1] vs 
score 1.0 [0.0–2.5], P,0.0001) (Figure 4). Likewise, PD15 
was lower for individuals with visually determined lung 
emphysema on chest CT compared to individuals without 
visually but quantitatively determined lung emphysema on 
both cardiac and chest CT. Similar results were observed in 
individuals without HIV infection (data not shown).
Using a lung emphysema threshold of .5% for 
%LAA-950 resulted in misclassification of 26 individuals 
(corresponding to 58%) on chest CT by not having visual 
emphysema, whereas none were misclassified on cardiac CT. 
Increasing the lung emphysema threshold to .10% reduced 
the misclassification rate on chest CT (from 58% to 32%) 
without affecting the misclassification rate on cardiac CT. 
In contrast, using a lung emphysema threshold of ,5% for 
%LAA-950 resulted in misclassification of 23 individuals 
(21%) on chest CT and 41 individuals (27%) on cardiac CT 
Figure 4 Association between visually and quantitatively assessed lung emphysema by cardiac and chest CT.
Notes: (A) %LAA-950 from chest CT and cardiac CT and (B) PD15 from chest CT and cardiac CT. Data are presented as mean and standard errors. Wilcoxon 
rank–sum test was used for calculation of P-values. Visual lung emphysema was determined by a radiologist (author: TK) blinded from the quantitatively determined lung 
emphysema.
Abbreviations: CT, computed tomography; %LAA-950, percent low attenuation area #950 Hounsfield units; PD15, 15th percentile density index.
?????????????
???
????
???
???????????????
?
??
???
???
???
???
???????
???????
?????????????????
???
????
????
????
???????????????????
?
?
?
?
?
????????
???????
?
??????????????????? ????????????????
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
5.
98
.2
16
 o
n 
19
-D
ec
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2018:13 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3327
lung density by cardiac CT scans
by having visual emphysema. Increasing the lung emphysema 
threshold to ,10% did not seem to affect the misclassifica-
tion rate on chest CT (from 21% to 22%) or on cardiac CT 
(from 27% to 28%).
Discussion
Lung density indices obtained from cardiac CT scans were 
at least moderately correlated with lung density indices 
obtained from chest CT scans. Furthermore, lung density 
indices obtained from both acquisition types performed 
equally with regard to discriminating airflow limitation and 
both were associated with visually quantified emphysema. 
Nevertheless, the accuracy of cardiac CT lung density indices 
was overall poor, and absolute scores should therefore be 
interpreted with care. Yet, taking all of the findings together, 
it seems that cardiac CT imaging may be used for lung 
emphysema quantification where association measures are 
of primary interest.
Complete volumetric CT is the best method for the detec-
tion of lung emphysema in vivo,20 and lung density indices 
assessed by chest CT scans represent well-validated measures 
of lung emphysema severity.15,21 In contrast, assessing lung 
emphysema from cardiac CT scans is expected to be impeded 
by several factors, including lower lung volumes,16 lack of 
assessment of the upper parts of the lungs, and technical CT 
parameters (eg, scan exposure parameters and reconstruction 
algorithms).17 Lung volume, which is known to be the source 
of largest variation in lung attenuation,22 is of greatest concern 
as cardiac CT scans include only a limited field of view that 
encompasses only the thorax at the level of the heart. The 
low accuracies found in this study do suggest that cardiac CT 
cannot be used for clinical purposes in individual patients. As 
cardiac CT was not performed during full inspiration, lung 
volume (and thus density) is likely to have a wide variation 
which we cannot compensate for using the present setup.
Despite the barriers mentioned above, cardiac CT scans 
were at least moderately correlated with chest CT scans with 
regard to determining lung density indices. Overall, PD15 
seemed to have the highest correlation in both individuals 
with and without HIV infection. Among patients with COPD, 
PD15 has also proven to be a potentially more useful marker 
for lung density decline compared to %LAA.23
We are not aware of studies comparing PD15 in car-
diac and chest CT scans. To the best of our knowledge, 
only the Multi-Ethnic Study of Atherosclerosis (MESA) 
has previously performed a comparability study between 
%LAA derived from cardiac and chest CT scans,24 which 
has provided a methodological fundament for a number of 
subsequent studies using lung emphysema from cardiac CT 
scans.25,26 In their study, the correlation between lung emphy-
sema threshold indices was found to be very strong (ρ=0.93); 
however, the analyses included only 24 individuals.24 
The lower correlation found in our study may be explained 
by several factors. MESA participants were asked to take 
deep breaths in both CT modalities, thereby minimizing 
the mean difference of lung volumes. Images were mostly 
obtained by early generation scanners and reconstruction 
algorithms, which may have affected quantification of lung 
density indices. Moreover, participants in the MESA study 
primarily included healthy individuals with a low tobacco 
exposure and with less airflow limitation. Individuals in the 
present study are expected to have more emphysema in the 
upper parts of the lungs due to a higher tobacco exposure, 
which may not be detected using cardiac CT imaging.
We also assessed the association of %LAA-950 with 
FEV
1
% predicted for both modalities. It is well-known 
that some individuals with COPD, regardless of severity 
of airflow limitation, have extensive lung emphysema and 
some have no trace of it.27 In some studies, the degree of 
%LAA emphysema has been associated with steeper lung 
function decline,28 whereas other studies have demonstrated 
a poor association between airflow limitation and lung 
emphysema.29 In the present study, the association with 
FEV
1
% predicted was poor for both imaging modalities. 
However, it should be noted that we did not include a high 
proportion of individuals with severe airflow limitation 
which may explain the poor association with FEV
1
% and the 
inability to discriminate airflow limitation. In addition, both 
imaging modalities performed equally poor with regard to 
discriminating airflow limitation. Thus, lung density indices 
from both cardiac and chest CT scans seem to provide similar 
information that is different from spirometric indices. This 
may, in part, be explained by the fact that airflow limitation 
in early disease is not exclusively accounted for by the extent 
of emphysema.
Visually determined lung emphysema provides distinct 
and complementary information compared to quantitatively 
determined lung emphysema. Previous studies have shown 
only moderate concordance between these two methods.30 
As expected, we also observed some degree of misclassifica-
tion when different thresholds for %LAA-950 were chosen 
and compared to visually determined lung emphysema. Yet, 
it was noteworthy that the false-negative rate was comparable 
for both CT modalities, whereas cardiac CT had no false-
positive rate. Thus, both CT modalities seem to perform 
equally bad in precluding visual lung emphysema; however, 
cardiac CT imaging seems to perform better in identifying 
visual lung emphysema compared to chest CT imaging. 
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The relatively poor performance of the quantitative indices 
may also be explained by the ability of the radiologist to 
detect emphysema. Visual emphysema was determined using 
a semi-quantitative cutoff of $2, corresponding to .10% 
emphysema, but choosing a different cutoff may change the 
performance of the quantitative indices.
Our study has several limitations. First, we did not 
perform repeated CT scans to evaluate reproducibility. The 
MESA was well-powered (n=119) to assess the reproduc-
ibility and found a high correlation and intra-class correlation 
coefficient for %LAA; however, PD15 was not evaluated. 
Second, although we included HIV-infected individuals, 
results were similar in HIV-uninfected individuals, and it 
seems unlikely that HIV status alone would change the 
correlation between emphysema indices derived from chest 
CT vs cardiac CT. Third, it should also be noted that we 
did not include additional static lung volume measures and 
we did not study interstitial abnormalities or compare high 
attenuation areas between the two modalities. Finally, for 
unknown reasons, some form of minor manual correction of 
lung segmentation was necessary for some of the cardiac CT 
scans; however, pathological conditions were not the cause 
of cardiac CT segmentation failures, and manual corrections 
did not affect the lung density scores.
Conclusion
Lung density indices obtained from cardiac CT scans were 
at least moderately associated with lung density indices 
obtained from chest CT scans. Although chest CT imaging 
is preferable, it seems that cardiac CT imaging may also be 
used for lung emphysema quantification, where association 
measures are of primary interest.
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Supplementary materials
Figure S1 Emphysema quantification by cardiac CT.
Notes: Male aged 54 years with emphysema (cardiac CT %LAA-950 =14.6% and chest CT %LAA-950 =18.2%). (A) Lung segmentation by chest CT; (B) lung volume 
segmentation by cardiac CT; and (C) axial cardiac CT slice; red pixels indicate laas.
Abbreviations: CT, computed tomography; %LAA-950, percent low attenuation area #950 Hounsfield units.
? ? ?
Table S1 Correlation and agreement between lung emphysema by cardiac and chest CT for individuals without HIV infection (n=51)
ρ P-valuea CCC P15 (%) P30 (%)
%LAA-910 cardiac CT vs %LAA-950 chest CT 0.62 ,0.0001 0.61 7.8 11.8
%LAA-920 cardiac CT vs %LAA-950 chest CT 0.61 ,0.0001 0.63 3.9 7.8
%LAA-930 cardiac CT vs %LAA-950 chest CT 0.50 ,0.0001 0.42 3.9 3.9
%LAA-940 cardiac CT vs %LAA-950 chest CT 0.42 ,0.0001 0.19 19.6 19.6
%LAA-950 cardiac CT vs %LAA-950 chest CT 0.40 ,0.0001 0.10 3.9 3.9
PD15 cardiac CT vs PD15 chest CT 0.74 ,0.0001 0.30 11.7 29.4
Notes: aP-value for Spearman’s correlation coefficient ρ. P15/P30, relative accuracy measure.
Abbreviations: CCC, concordance correlation coefficient; CT, computed tomography; %LAA, percent low attenuation area; PD15, 15th percentile density index.
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